426 related articles for article (PubMed ID: 30474051)
1. Dietary Polysaccharides in the Amelioration of Gut Microbiome Dysbiosis and Metabolic Diseases.
Ahmadi S; Mainali R; Nagpal R; Sheikh-Zeinoddin M; Soleimanian-Zad S; Wang S; Deep G; Kumar Mishra S; Yadav H
Obes Control Ther; 2017; 4(3):. PubMed ID: 30474051
[TBL] [Abstract][Full Text] [Related]
2. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
[TBL] [Abstract][Full Text] [Related]
3. Prebiotic effects: metabolic and health benefits.
Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
[TBL] [Abstract][Full Text] [Related]
4. Prebiotics as a modulator of gut microbiota in paediatric obesity.
Nicolucci AC; Reimer RA
Pediatr Obes; 2017 Aug; 12(4):265-273. PubMed ID: 27072327
[TBL] [Abstract][Full Text] [Related]
5. Targeting Gut Microbiota With Natural Polysaccharides: Effective Interventions Against High-Fat Diet-Induced Metabolic Diseases.
Sun CY; Zheng ZL; Chen CW; Lu BW; Liu D
Front Microbiol; 2022; 13():859206. PubMed ID: 35369480
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota in obesity and metabolic disorders.
Sanz Y; Santacruz A; Gauffin P
Proc Nutr Soc; 2010 Aug; 69(3):434-41. PubMed ID: 20540826
[TBL] [Abstract][Full Text] [Related]
7. Gut commensal
Wu TR; Lin CS; Chang CJ; Lin TL; Martel J; Ko YF; Ojcius DM; Lu CC; Young JD; Lai HC
Gut; 2019 Feb; 68(2):248-262. PubMed ID: 30007918
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiome supplementation as therapy for metabolic syndrome.
Antony MA; Chowdhury A; Edem D; Raj R; Nain P; Joglekar M; Verma V; Kant R
World J Diabetes; 2023 Oct; 14(10):1502-1513. PubMed ID: 37970133
[TBL] [Abstract][Full Text] [Related]
9. The gut microbiota as a novel regulator of cardiovascular function and disease.
Battson ML; Lee DM; Weir TL; Gentile CL
J Nutr Biochem; 2018 Jun; 56():1-15. PubMed ID: 29427903
[TBL] [Abstract][Full Text] [Related]
10. Nutritionally Attenuating the Human Gut Microbiome To Prevent and Manage Metabolic Syndrome.
Louis-Jean S; Martirosyan D
J Agric Food Chem; 2019 Nov; 67(46):12675-12684. PubMed ID: 31661963
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota and metabolic syndrome.
Festi D; Schiumerini R; Eusebi LH; Marasco G; Taddia M; Colecchia A
World J Gastroenterol; 2014 Nov; 20(43):16079-94. PubMed ID: 25473159
[TBL] [Abstract][Full Text] [Related]
12. Gut Microbiota and Obesity: A Role for Probiotics.
Abenavoli L; Scarpellini E; Colica C; Boccuto L; Salehi B; Sharifi-Rad J; Aiello V; Romano B; De Lorenzo A; Izzo AA; Capasso R
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31703257
[TBL] [Abstract][Full Text] [Related]
13. Gut Microbiota as a Therapeutic Target for Metabolic Disorders.
Okubo H; Nakatsu Y; Kushiyama A; Yamamotoya T; Matsunaga Y; Inoue MK; Fujishiro M; Sakoda H; Ohno H; Yoneda M; Ono H; Asano T
Curr Med Chem; 2018; 25(9):984-1001. PubMed ID: 28990516
[TBL] [Abstract][Full Text] [Related]
14. Possibilities of therapeutic manipulation of the gut microbiota.
Drastich P; Bajer L; Kverka M
Vnitr Lek; 2018; 64(6):665-671. PubMed ID: 30223665
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT).
Lee P; Yacyshyn BR; Yacyshyn MB
Diabetes Obes Metab; 2019 Mar; 21(3):479-490. PubMed ID: 30328245
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota and Metabolic Disorders: Advances in Therapeutic Interventions.
Akash MSH; Fiayyaz F; Rehman K; Sabir S; Rasool MH
Crit Rev Immunol; 2019; 39(4):223-237. PubMed ID: 32421966
[TBL] [Abstract][Full Text] [Related]
17. Influence of functional food components on gut health.
Wan MLY; Ling KH; El-Nezami H; Wang MF
Crit Rev Food Sci Nutr; 2019; 59(12):1927-1936. PubMed ID: 29381385
[TBL] [Abstract][Full Text] [Related]
18. The role of probiotics on each component of the metabolic syndrome and other cardiovascular risks.
Miglioranza Scavuzzi B; Miglioranza LH; Henrique FC; Pitelli Paroschi T; Lozovoy MA; Simão AN; Dichi I
Expert Opin Ther Targets; 2015; 19(8):1127-38. PubMed ID: 25872805
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiome and type 2 diabetes: where we are and where to go?
Sharma S; Tripathi P
J Nutr Biochem; 2019 Jan; 63():101-108. PubMed ID: 30366260
[TBL] [Abstract][Full Text] [Related]
20. Designing future prebiotic fiber to target metabolic syndrome.
Jakobsdottir G; Nyman M; Fåk F
Nutrition; 2014 May; 30(5):497-502. PubMed ID: 24262515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
